These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1741615)

  • 1. Regulation of human immunodeficiency virus replication.
    Cullen BR
    Annu Rev Microbiol; 1991; 45():219-50. PubMed ID: 1741615
    [No Abstract]   [Full Text] [Related]  

  • 2. An immune control model for viral replication in the CNS during presymptomatic HIV infection.
    McCrossan M; Marsden M; Carnie FW; Minnis S; Hansoti B; Anthony IC; Brettle RP; Bell JE; Simmonds P
    Brain; 2006 Feb; 129(Pt 2):503-16. PubMed ID: 16317019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular basis of HIV-1 latency - part I: physiology of HIV-1 latency].
    Schwartz C; Le Douce V; Cherrier T; Redel L; Marban C; Aunis D; Rohr O
    Med Sci (Paris); 2010 Feb; 26(2):159-63. PubMed ID: 20188047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
    Shuh M; Hill SA; Derse D
    Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
    Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
    Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific interaction of TFII-I with an upstream element on the HIV-1 LTR regulates induction of latent provirus.
    Malcolm T; Kam J; Pour PS; Sadowski I
    FEBS Lett; 2008 Nov; 582(28):3903-8. PubMed ID: 18976654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of nef alleles on replication of human immunodeficiency virus type 1.
    Zazopoulos E; Haseltine WA
    Virology; 1993 May; 194(1):20-7. PubMed ID: 7683154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.
    Bukrinsky MI; Stanwick TL; Dempsey MP; Stevenson M
    Science; 1991 Oct; 254(5030):423-7. PubMed ID: 1925601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Viral dynamics in human immunodeficiency virus type 1 infection.
    Wei X; Ghosh SK; Taylor ME; Johnson VA; Emini EA; Deutsch P; Lifson JD; Bonhoeffer S; Nowak MA; Hahn BH
    Nature; 1995 Jan; 373(6510):117-22. PubMed ID: 7529365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular approaches to inhibit HIV-1 tat expression and functions.
    Grossi MP; Caputo A; Zucchini S; Bozzini R; Marconi PC; Manservigi R; Barbanti-Brodano G; Balboni PG
    Year Immunol; 1993; 7():199-204. PubMed ID: 8396820
    [No Abstract]   [Full Text] [Related]  

  • 11. 5' long terminal repeat (LTR)-selective methylation of latently infected HIV-1 provirus that is demethylated by reactivation signals.
    Ishida T; Hamano A; Koiwa T; Watanabe T
    Retrovirology; 2006 Oct; 3():69. PubMed ID: 17034647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of interaction between HIV and Mycoplasma arginini in vitro].
    Miller GG; Rakovskaia IV; Pokidysheva LN; Korablina EV; Titova IV
    Zh Mikrobiol Epidemiol Immunobiol; 2009; (4):49-53. PubMed ID: 19715203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual phasic suppression of viral replication following de novo human immunodeficiency virus type 1 (HIV-1) infection in lymphocytes of asymptomatic HIV-1 carriers.
    Kannagi M; Nakamura T; Akari H; Kuroda MJ; Fujii M; Oka S; Iwamoto A; Kurata T; Higashi D; Harada S
    Leukemia; 1997 Apr; 11 Suppl 3():545-7. PubMed ID: 9209452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Specific suppression of human CD4 surface expression by Nef from the pathogenic simian immunodeficiency virus SIVmac239open.
    Foster JL; Anderson SJ; Frazier AL; Garcia JV
    Virology; 1994 Jun; 201(2):373-9. PubMed ID: 8184546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gradual shutdown of virus production resulting in latency is the norm during the chronic phase of human immunodeficiency virus replication and differential rates and mechanisms of shutdown are determined by viral sequences.
    Li XD; Moore B; Cloyd MW
    Virology; 1996 Nov; 225(1):196-212. PubMed ID: 8918547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
    Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC
    Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new recombinant virus system for the study of HIV-1 entry and inhibition.
    Roman F; Ammerlaan W; Plesseria JM; Deroo S; Muller CP; Arendt V; Schneider F; Hemmer R; Schmit JC
    J Virol Methods; 2006 Jan; 131(1):99-104. PubMed ID: 16111774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection and replication of Tat- human immunodeficiency viruses: genetic analyses of LTR and tat mutations in primary and long-term human lymphoid cells.
    Chang LJ; Zhang C
    Virology; 1995 Aug; 211(1):157-69. PubMed ID: 7645208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TLR5 stimulation is sufficient to trigger reactivation of latent HIV-1 provirus in T lymphoid cells and activate virus gene expression in central memory CD4+ T cells.
    Thibault S; Imbeault M; Tardif MR; Tremblay MJ
    Virology; 2009 Jun; 389(1-2):20-5. PubMed ID: 19447460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A replication-deficient human immunodeficiency virus-1 genome as an interference-inducing provirus.
    Federico M; Nappi F; Mavilio F; Verani P
    Antibiot Chemother (1971); 1996; 48():217-25. PubMed ID: 8726528
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.